Zealand Pharma

Measuring tape on top of cash
Biotech

What’s next for Roche’s expensive obesity pipeline?

It’s been less than two years since Roche dove into the obesity space with its $2.7 billion acquisition of Carmot—but a lot has changed since then.
James Waldron Sep 19, 2025 10:16am
dominoes stop stall halt end red

'Several concerning observations': FDA sheds light on rejections

Sep 5, 2025 10:45am
weight loss scale weigh measure tape obesity overweight

Zealand's dual agonist tied to 11% weight loss in phase 1b

Jun 18, 2025 3:00pm
Paraglider over Lake Tahoe

Weight of market pressures pushes Novo CEO out—Chutes & Ladders

May 23, 2025 8:30am
Parachute over a mountain in Switzerland

Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders

Apr 25, 2025 8:30am
finance numbers tape money

Roche pays Zealand $1.6B to codevelop amylin obesity asset

Mar 12, 2025 5:23am